However, in our experience, we always successfully transfect various types of 0-100 μM ASOs, including phosphorodiamidate morpholino oligomer (PMO), 2′-O-methyl oligonucleotide (2OMe) and peptide-conjugated PMO (PPMO) with Endo-Porter reagent in the case of DMD patient-derived MYOD1-UDCs. The gene discussed is MYOD1; the disease is Duchenne muscular dystrophy.